No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients

  1. Collazos, J.
  2. Pérez-Is, L.
  3. de la Fuente, B.
  4. Morano, L.
  5. Rivas-Carmenado, M.
  6. Rodriguez, M.
  7. Romero-Favela, A.
  8. de Jesús Fonseca-González, G.
  9. Melón, S.
  10. Diaz-Arias, J.
  11. Valle-Garay, E.
  12. Asensi, V.
Journal:
Scientific Reports

ISSN: 2045-2322

Year of publication: 2024

Volume: 14

Issue: 1

Type: Article

DOI: 10.1038/S41598-024-57845-X GOOGLE SCHOLAR lock_openOpen access editor